Correlation Between TRON and Tissue Regenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TRON and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRON and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TRON and Tissue Regenix Group, you can compare the effects of market volatilities on TRON and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRON with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRON and Tissue Regenix.

Diversification Opportunities for TRON and Tissue Regenix

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between TRON and Tissue is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding TRON and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and TRON is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRON are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of TRON i.e., TRON and Tissue Regenix go up and down completely randomly.

Pair Corralation between TRON and Tissue Regenix

Assuming the 90 days trading horizon TRON is expected to generate 4.39 times more return on investment than Tissue Regenix. However, TRON is 4.39 times more volatile than Tissue Regenix Group. It trades about 0.09 of its potential returns per unit of risk. Tissue Regenix Group is currently generating about -0.01 per unit of risk. If you would invest  6.01  in TRON on October 9, 2024 and sell it today you would earn a total of  20.99  from holding TRON or generate 349.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy59.76%
ValuesDaily Returns

TRON  vs.  Tissue Regenix Group

 Performance 
       Timeline  
TRON 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TRON are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, TRON exhibited solid returns over the last few months and may actually be approaching a breakup point.
Tissue Regenix Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

TRON and Tissue Regenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TRON and Tissue Regenix

The main advantage of trading using opposite TRON and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRON position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.
The idea behind TRON and Tissue Regenix Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years